Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 56

Sort by

Sort Order Select

Journal Articles

Heme-Mediated Tau Phosphorylation Is Critical for Neuroaxonal Damage and Cognitive Impairment in Sickle Cell Disease

Nandinii Sekar, Shane C Lenhart, Paritosh Mondal, Lesley Foley, Samit Ghosh, Enrico M Novelli, T Kevin Hitchens, Xiaoming Hu, Rimi Hazra

Blood (2024) 144 (Supplement 1): 624.

https://doi.org/10.1182/blood-2024-211179

Published: 2024

Journal Articles

Higher Hemoglobin Level Correlates with Increased Tissue Oxygenation in a Comprehensive Profile of Hemorheology in Sickle Cell Disease

Christine Saber, Elizabeth Meinert-Spyker, Lara Abdelmohsen, Brian J Philips, Joel Dzidzorvi Kwame Disu, Nahom Mossazghi, Nelly Kiriza, Seyed Mehdi Nouraie, Olubusola Oluwole, Laura M. DeCastro, Adam C Straub, Enrico M Novelli, Sossena Wood, Julia Xu

Blood (2024) 144 (Supplement 1): 294.

https://doi.org/10.1182/blood-2024-203346

Published: 2024

Journal Articles

A Phase 1b/2 Study of the Efficacy and Safety of Combination Hydroxyurea and Dose-Escalated Erythropoietin for Treatment of Anemia in Sickle Cell Disease (ACHiEvE-SCD)

Titilope A Adeyemo, Nelly Kiriza, Feyisayo T. Oluwole, Mark Jelinek, Jude Jonassaint, Olubusola Oluwole, Christine Saber, Brian J Philips, Olusegun-Joseph D Akinsanya, Vincent O Osunkalu, Laura M. DeCastro, Enrico M Novelli, Julia Z Xu

Blood (2024) 144 (Supplement 1): 178.

https://doi.org/10.1182/blood-2024-205261

Published: 2024

Journal Articles

Sublingual Microvascular Findings in Sickle Cell Disease and Correlation with Neurocognition

John Tukakira, Michael Carpenter, Beth E. Snitz, Caterina Rosano, Enrico M Novelli, Olubusola Oluwole

Blood (2024) 144 (Supplement 1): 5357.

https://doi.org/10.1182/blood-2024-212021

Published: 2024

Journal Articles

Trends of Opioid Prescribing and Vaso-Occlusive Crises in Sickle Cell Disease in the U.S. (2011-2023)

Kevin Y Xu, Terri Victoria Newman, Lakeya S. McGill, Enrico M Novelli, Cheryl Hillery, Joanna L Buss, Ruizi Huang, Joanne Salas, Fanghong Dong, Dustin Stwalley, Shiyuan A Liu, Jeffrey Scherrer, Tashalee R Brown, Taewoo Park, Marc R Larochelle, Richard A Grucza, Charles R. Jonassaint

Blood (2024) 144 (Supplement 1): 5065.

https://doi.org/10.1182/blood-2024-209330

Published: 2024

Journal Articles

Results from a Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Tebapivat (AG-946) in Patients with Sickle Cell Disease

Julia Z Xu, Enrico M Novelli, Jean-Antoine Ribeil, Andreas Glenthøj, Srila Gopal, Hanny Al-Samkari, Modupe Idowu, Jenny Despotovic, Spurthi Patil, Xiaoshu Dai, Abdullah Al Masud, Michael Callaghan, Fuad El Rassi

Blood (2024) 144 (Supplement 1): 2496.

https://doi.org/10.1182/blood-2024-203509

Published: 2024

Journal Articles

Use of Chronic Blood Transfusion Therapies and Pharmaceutical Disease Modifying Treatments in Sickle Cell Disease: A Retrospective Cohort Analysis (2014-2021)

Terri Victoria Newman, Jingye Yang, Aaron Haubner, Melissa Anderson, Darrell J Triulzi, Enrico M Novelli

Blood (2024) 144 (Supplement 1): 3690.

https://doi.org/10.1182/blood-2024-203182

Published: 2024

Journal Articles

Inhibition of Purine Nucleoside Phosphorylase Is a Promising Anti-Sickling Approach for Sickle Cell Disease

Adekunle Emmanuel Alagbe, Lynda Little-Ihrig, Brian J Philips, Stephanie M Mutchler, Julia Z Xu, Edwin K Jackson, Stevan Tofovic, Enrico M Novelli

Blood (2024) 144 (Supplement 1): 3861.

https://doi.org/10.1182/blood-2024-199595

Published: 2024

Journal Articles

Predicting Hemoglobin Response to Hydroxyurea and Voxelotor in Adults with Sickle Cell Disease

Christine Saber, Rashmi Madhukar, Olubusola Oluwole, Laura M. Decastro, Enrico M Novelli, Julia Xu

Blood (2023) 142 (Supplement 1): 3895.

https://doi.org/10.1182/blood-2023-174487

Published: 2023

Journal Articles

Racial Discrimination and Pain in Adults with Sickle Cell Disease: Depression As a Mediator

Donald J Bearden, Kim Ono, Lindsey L Cohen, Julia A. O'Brien, Charles R. Jonassaint, Soumitri Sil, Carlton Dampier, Elna N. Saah, Enrico M Novelli

Blood (2023) 142 (Supplement 1): 2371.

https://doi.org/10.1182/blood-2023-183006

Published: 2023

Journal Articles

IL-27 Promotes Neutrophil Extracellular Trap Generation in Sickle Cell Disease

Adekunle Emmanuel Alagbe, Enrico M Novelli, Prithu Sundd

Blood (2023) 142 (Supplement 1): 5283.

https://doi.org/10.1182/blood-2023-189264

Published: 2023

Journal Articles

Circulating NETs Promote Platelet-TLR9 Dependent Acute Chest Syndrome in Sickle Cell Disease

Rikesh K Dubey, Omika Katoch, Enrico M Novelli, Prithu Sundd

Blood (2023) 142 (Supplement 1): 1121.

https://doi.org/10.1182/blood-2023-187381

Published: 2023

Journal Articles

Addressing Chronic Anemia in Sickle Cell Disease: Characterizing Erythropoiesis-Stimulating Agent (ESA) Utilization and Practice Patterns Among Providers

Iuliia Kovalenko, Mitali Shah, Nelly Kiriza, Enrico M Novelli, Laura M. Decastro, Julia Xu

Blood (2023) 142 (Supplement 1): 3681.

https://doi.org/10.1182/blood-2023-180334

Published: 2023

Journal Articles

Is CBD ready for prime time in sickle cell disease?

Susanna A. Curtis, Enrico M. Novelli

Blood (2023) 141 (2): 132–133.

https://doi.org/10.1182/blood.2022018393

Published: 2023

Journal Articles

White Matter Injury in Sickle Cell Mice Is Associated with Reduced Neurocognitive Function and Activation of Astrocytes

Rimi Hazra, Hongjan Pu, Lesley M. Foley, T. Kevin Hitchens, Lynda Little-Ihrig, Samit Ghosh, Solomon Fiifi Ofori-Acquah, Xiaoming Hu, Enrico M. Novelli

Blood (2022) 140 (Supplement 1): 441–442.

https://doi.org/10.1182/blood-2022-169094

Published: 2022

Journal Articles

Myeloid Specific HO-1-SIRT1-p53 Nexus Protects Against Iron Induced Chronic Liver Injury in Sickle Cell Disease

Omika Katoch, Ziming Li, Ravi Vats, Rikesh K. Dubey, Tomasz W. Kaminski, Tomasz Brzoska, Prithu Sundd, Enrico M. Novelli, Tirthadipa Pradhan-Sundd

Blood (2022) 140 (Supplement 1): 8251.

https://doi.org/10.1182/blood-2022-170095

Published: 2022

Journal Articles

Notch Pathway Driven Delayed Dedifferentiation of Liver Sinusoidal Endothelium Impacts Liver-Directed Gene Transfer in Hemophilia-a Mice

Tirthadipa Pradhan-Sundd, Tomasz W. Kaminski, Rikesh K.K. Dubey, Shweta Gudapati, Omika Katoch, Jesús Tejero, Enrico M. Novelli, Margaret V. Ragni, Prithu Sundd

Blood (2022) 140 (Supplement 1): 10658–10659.

https://doi.org/10.1182/blood-2022-170050

Published: 2022

Journal Articles

Barriers to the Use of Disease-Modifying Treatments in Sickle Cell Disease: A Survey of Patients and Caregivers

Christina Kazarov, Enrico M. Novelli, Sandra Kane-Gill, Charles L Jonassaint, Maggie Jalowsky, Cory A. Lewis, Terri Newman

Blood (2022) 140 (Supplement 1): 5152–5153.

https://doi.org/10.1182/blood-2022-170881

Published: 2022

Journal Articles

Trends of Disease Modifying Treatment Use in Sickle Cell Disease: Retrospective Analysis of Claims Data, 2014-2020

Terri Newman, Jingye Yang, Kangho Suh, Charles Jonassaint, Sandra Kane-Gill, Enrico M Novelli

Blood (2022) 140 (Supplement 1): 1389–1390.

https://doi.org/10.1182/blood-2022-159197

Published: 2022

Journal Articles

The Role of TSP-1, TGF-B1 and Galectin-3 in the Pathogenesis of ACS in Sickle Cell Disease

Ali San, Gowtham K Annarapu, Lynda Little-Ihrig, Enrico M. Novelli, Sruti Shiva

Blood (2022) 140 (Supplement 1): 8233–8234.

https://doi.org/10.1182/blood-2022-165434

Published: 2022

NARROW

Heme-Mediated Tau Phosphorylation Is Critical for Neuroaxonal Damage and Cognitive Impairment in Sickle Cell Disease

Higher Hemoglobin Level Correlates with Increased Tissue Oxygenation in a Comprehensive Profile of Hemorheology in Sickle Cell Disease

A Phase 1b/2 Study of the Efficacy and Safety of Combination Hydroxyurea and Dose-Escalated Erythropoietin for Treatment of Anemia in Sickle Cell Disease (ACHiEvE-SCD)

Sublingual Microvascular Findings in Sickle Cell Disease and Correlation with Neurocognition

Trends of Opioid Prescribing and Vaso-Occlusive Crises in Sickle Cell Disease in the U.S. (2011-2023)

Results from a Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Tebapivat (AG-946) in Patients with Sickle Cell Disease

Use of Chronic Blood Transfusion Therapies and Pharmaceutical Disease Modifying Treatments in Sickle Cell Disease: A Retrospective Cohort Analysis (2014-2021)

Inhibition of Purine Nucleoside Phosphorylase Is a Promising Anti-Sickling Approach for Sickle Cell Disease

Predicting Hemoglobin Response to Hydroxyurea and Voxelotor in Adults with Sickle Cell Disease

Racial Discrimination and Pain in Adults with Sickle Cell Disease: Depression As a Mediator

IL-27 Promotes Neutrophil Extracellular Trap Generation in Sickle Cell Disease

Circulating NETs Promote Platelet-TLR9 Dependent Acute Chest Syndrome in Sickle Cell Disease

Addressing Chronic Anemia in Sickle Cell Disease: Characterizing Erythropoiesis-Stimulating Agent (ESA) Utilization and Practice Patterns Among Providers

Is CBD ready for prime time in sickle cell disease?

White Matter Injury in Sickle Cell Mice Is Associated with Reduced Neurocognitive Function and Activation of Astrocytes

Myeloid Specific HO-1-SIRT1-p53 Nexus Protects Against Iron Induced Chronic Liver Injury in Sickle Cell Disease

Notch Pathway Driven Delayed Dedifferentiation of Liver Sinusoidal Endothelium Impacts Liver-Directed Gene Transfer in Hemophilia-a Mice

Barriers to the Use of Disease-Modifying Treatments in Sickle Cell Disease: A Survey of Patients and Caregivers

Trends of Disease Modifying Treatment Use in Sickle Cell Disease: Retrospective Analysis of Claims Data, 2014-2020

The Role of TSP-1, TGF-B1 and Galectin-3 in the Pathogenesis of ACS in Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only